BioWorld-International-2004-06-09
IDM Seeking EUR92 Million In IPO To Fund Programs In Cancer
IDM Seeking EUR92 Million In IPO To Fund Programs In Cancer
PARIS - Immuno-Designed Molecules SA proposed an IPO on the Nouveau Marche of the Euronext stock exchange in Paris last week, offering 8.1 million shares at 10.50 to 12.20 per share. (BioWorld International)

